BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7788958)

  • 1. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
    Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute bronchitis and pneumonia with cefaclor.
    Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
    Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
    Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG).
    Khan S; Javaid A; Ghori RA; Mahmood K; Anwer N; Khan SU; Iqbal ZH; Rahman F; Ullah S; Imran K; Akhter N; Khan MK; Siddqui SJ; Fareed A; Khan MH
    J Pak Med Assoc; 2003 Aug; 53(8):338-45. PubMed ID: 14558738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT; Awad CE; Ali A; Matyas R; Vital AC; Silva CO; Dainesi SM; Salazar MS; Nakatani J
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
    Dark D
    Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ
    Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
    Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
    Wettengel R; Vetter N; Waardenburg FA
    J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS
    Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefaclor AF: correlation of microbiology and clinical outcome.
    Thornsberry C
    Postgrad Med J; 1992; 68 Suppl 3():S10-6. PubMed ID: 1287612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
    Smialowicz CR
    Clin Ther; 1982; 5(2):113-9. PubMed ID: 7159894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
    Beumer HM; Veldkamp J
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.